Literature DB >> 6978903

SAA suppression of immune response in vitro: evidence for an effect on T cell-macrophage interaction.

M A Aldo-Benson, M D Benson.   

Abstract

SAA has been shown previously to inhibit the in vitro antibody response of normal murine spleen cells to SRBC. This effect is nonspecific but does not directly suppress B cells. To evaluate the mechanisms of this suppression, the in vitro antibody response to SRBC was studied using cells from cytoxan-treated mice. No evidence for preformed suppressor cells was found. Also, preincubation of normal cells with SAA failed to reveal evidence for the generation of suppressor cells in vitro. The addition of 2-mercaptoethanol to cultures completely reversed the suppression caused by SAA. Addition of either normal T cells or normal macrophages to cultures partially reversed suppression caused by SAA, but only a combination of T cells and macrophages could completely reverse the suppression. These data are consistent with an effect of SAA on macrophage-T cell interaction in the generation of the immune response to T-dependent antigen. No evidence for the participation of suppressor cells as has been demonstrated for alpha-fetoprotein was found.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6978903

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  13 in total

1.  A novel cis-acting element is essential for cytokine-mediated transcriptional induction of the serum amyloid A gene in nonhepatic cells.

Authors:  A Ray; B K Ray
Journal:  Mol Cell Biol       Date:  1996-04       Impact factor: 4.272

Review 2.  Reactive (secondary) amyloidosis and its pathogenesis.

Authors:  C P Maury
Journal:  Rheumatol Int       Date:  1984       Impact factor: 2.631

3.  Development of quantitative mass spectrometric immunoassay for serum amyloid A.

Authors:  Olgica Trenchevska; Hussein N Yassine; Chad R Borges; Randall W Nelson; Dobrin Nedelkov
Journal:  Biomarkers       Date:  2016-07-22       Impact factor: 2.658

4.  Serum amyloid A 2.2 refolds into a octameric oligomer that slowly converts to a more stable hexamer.

Authors:  Yun Wang; Saipraveen Srinivasan; Zhuqiu Ye; J Javier Aguilera; Maria M Lopez; Wilfredo Colón
Journal:  Biochem Biophys Res Commun       Date:  2011-03-31       Impact factor: 3.575

Review 5.  Regulation of serum amyloid A protein expression during the acute-phase response.

Authors:  L E Jensen; A S Whitehead
Journal:  Biochem J       Date:  1998-09-15       Impact factor: 3.857

6.  Human serum amyloid A genes are expressed in monocyte/macrophage cell lines.

Authors:  S Urieli-Shoval; R L Meek; R H Hanson; N Eriksen; E P Benditt
Journal:  Am J Pathol       Date:  1994-09       Impact factor: 4.307

7.  Expression of apolipoprotein serum amyloid A mRNA in human atherosclerotic lesions and cultured vascular cells: implications for serum amyloid A function.

Authors:  R L Meek; S Urieli-Shoval; E P Benditt
Journal:  Proc Natl Acad Sci U S A       Date:  1994-04-12       Impact factor: 11.205

8.  Identification of a specific interleukin 1 inhibitor in the urine of febrile patients.

Authors:  Z Liao; R S Grimshaw; D L Rosenstreich
Journal:  J Exp Med       Date:  1984-01-01       Impact factor: 14.307

9.  Characteristics of suppressor factors generated from human mononuclear cells using concanavalin A and C-reactive protein.

Authors:  A G Wangel; S Kontiainen
Journal:  Clin Exp Immunol       Date:  1983-08       Impact factor: 4.330

10.  The acute phase response in parasite infection. Nippostrongylus brasiliensis in the mouse.

Authors:  L R Lamontagne; J Gauldie; A D Befus; K P McAdam; M L Baltz; M B Pepys
Journal:  Immunology       Date:  1984-08       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.